FCMT
RXST icon

Founders Capital Management (Texas)’s RxSight RXST Stock Holding History

Founders Capital Management (Texas)’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$10.4K – 425
2025
Q4 		$10.4K Hold
1,000
– – 0.01% 309
2025
Q3 		$8.99K Buy
+1,000
New +$8.78K ﹤0.01% 300

Other funds holding RXST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
NSGL
No Street GP LP San Francisco, California $1.5B AUM 34.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Founders Capital Management (Texas)'s RXST Position: Q1 2026 in Review

Founders Capital Management (Texas) sold out of RxSight (RXST) in Q1 2026, closing a stake of 1,000 shares — an estimated $10.4K sold.

Founders Capital Management (Texas) first reported a position in RXST in Q3 2025 and held it in 2 quarters. The position peaked at $10.4K in Q4 2025. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • Founders Capital Management (Texas) reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • Founders Capital Management (Texas) sold 1,000 RxSight shares in Q1 2026, an estimated $10.4K.
  • Founders Capital Management (Texas) first reported a position in RxSight in Q3 2025 and held it in 2 quarters.
  • Founders Capital Management (Texas)'s RxSight position peaked at $10.4K in Q4 2025.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on Founders Capital Management (Texas)'s 13F filing for Q1 2026, filed 21 Apr 2026.